Sakuyama, N.; Nagayasu, K.; Abe, Y.; Ochiai, T.; Shibasaki, F.
Plasma 5-Fluorouracil Exposure, Clinical Outcomes, and Therapeutic Drug Monitoring in Advanced Colorectal Cancer. Cancers 2026, 18, 1673.
https://doi.org/10.3390/cancers18101673
AMA Style
Sakuyama N, Nagayasu K, Abe Y, Ochiai T, Shibasaki F.
Plasma 5-Fluorouracil Exposure, Clinical Outcomes, and Therapeutic Drug Monitoring in Advanced Colorectal Cancer. Cancers. 2026; 18(10):1673.
https://doi.org/10.3390/cancers18101673
Chicago/Turabian Style
Sakuyama, Naoki, Kiichi Nagayasu, Yu Abe, Takumi Ochiai, and Futoshi Shibasaki.
2026. "Plasma 5-Fluorouracil Exposure, Clinical Outcomes, and Therapeutic Drug Monitoring in Advanced Colorectal Cancer" Cancers 18, no. 10: 1673.
https://doi.org/10.3390/cancers18101673
APA Style
Sakuyama, N., Nagayasu, K., Abe, Y., Ochiai, T., & Shibasaki, F.
(2026). Plasma 5-Fluorouracil Exposure, Clinical Outcomes, and Therapeutic Drug Monitoring in Advanced Colorectal Cancer. Cancers, 18(10), 1673.
https://doi.org/10.3390/cancers18101673